Learning pointsExercise training increases walking performance and physical function and should be recommended in TAK patients.One of the possible underlying mechanisms may be an improved microvascular milieu leading to a better match between muscle oxygen supply and demand during exercise.

Introduction
============

Takayasu arteritis (TAK) is a rare chronic inflammatory vasculitis that predominantly leads to stenosis, occlusion, and/or aneurysm of the aorta and its main branches.[@yty123-B1] Takayasu arteritis mainly occurs in young females.[@yty123-B1] Clinical manifestations are diminished/absent peripheral pulses, asymmetric blood pressure in either upper or lower limbs, peripheral ischaemia, and arterial claudication.[@yty123-B1] Daily life activities may be compromised, with consequent reduced physical function, and decreased quality of life.[@yty123-B1] Patients with TAK are at higher risk of cardiovascular events.[@yty123-B4] It has recently been shown that exercise training is effective and well-tolerated in female patients with TAK[@yty123-B3] and that may increase walking performance and quality of life in a male patient with arteritis and symptoms of claudication of lower limbs.[@yty123-B5] However, the underlying mechanisms remain poorly investigated. In patients with lower extremity artery disease (LEAD), presenting similar symptoms of claudication than TAK patients, adaptations to exercise training mainly reside at the skeletal muscle level.[@yty123-B6] Therefore, one may hypothesize that similar adaptations may also occur in symptomatic TAK patients.

Near-infrared spectroscopy (NIRS) is a non-invasive system measuring muscle oxygen saturation \[StO~2~ (%)\], indicative of tissue oxygenation.[@yty123-B7] Near-infrared spectroscopy-assessed StO~2~ may therefore provide information on the balance between oxygen consumption and delivery within the skeletal muscle at rest and during exercise,[@yty123-B7] contributing to new mechanistic insights following exercise training in TAK patients.

We presented here a review of the literature in the topic of exercise training and arteritis and the first case of a 28-year-old man with TAK and symptoms of arterial lower limb claudication being evaluated with NIRS during exercise before and after a 12-week supervised exercise training (SET). In addition, physical function of lower extremities was also assessed.

Patient information
===================

TimeEventsBetween 18 and 16 months prior to supervised exercise training (SET)Diagnosis of TAKCRP = 292 mg L^−1^Lower limb claudication: 50 mTreatment: i.v. corticosteroid therapy, Prednisone 45 mg day^−1^ (1 mg kg day^−1^) and Methotrexate 10 mg week^−1^Between 16 and 12 months prior to SETLower limb claudication: 200 mCRP = 1 mg L^−1^Treatment: Methotrexate 10 mg week^−1^; Prednisone decrease until 17.5 mg day^−1^Between 12 and 11 months prior to SETAbdominal painCRP = 91 mg L^−1^Treatment: Prednisone 40 mg day^−1^ and Tocilizumab 8 mg kg month^−1^, Methotrexate was stoppedBetween 11 and 7 months prior to SETLower limb claudication: 200 mNo significant sign of inflammationCRP = 1 mg L^−1^Treatment: Prednisone decrease until 10 mg day^−1^, Tocilizumab 8 mg kg month^−1^Between 4 months to the beginning of SETLower limb claudication: 200 mNo significant sign of inflammationCRP = 1 mg L^−1^Treatment: Prednisone decreases until 5 mg day^−1^, Tocilizumab 8 mg kg month^−1^SET was initiatedFollowing SETSignificant improvement in walking performances and physical functionNo significant sign of inflammationCRP \<1 mg L^−1^A 28-year-old man (body mass index 17.8 kg/m^2^) with TAK, renal artery stenosis with hypertension and symptoms of arterial lower limbs claudication was investigated ([*Figure 1*](#yty123-F1){ref-type="fig"}). The patient had no active comorbidities and was non-smoker. Eighteen months prior to SET, the patient was hospitalized for abdominal and lower extremity pain (claudication: 50 m), myalgia, and fever. Peripheral pulses were present only in femoral arteries; ankle-brachial index was 0.80 (right leg) and 0.57 (left leg). Vascular Duplex examination revealed thickness of the arterial wall and stenosis/occlusion of digestive, renal, and ilio-femoral arterial axes. Systemic inflammation (CRP) was 292 mg L^−1^. Treatment included intravenous corticosteroid therapy, followed by Prednisone 1 mg kg^−1^ day^−1^ and Methotrexate 10 mg week^−1^. After 6 months, by reason of an adverse evolution, with abdominal pain, persistence of significant lower limb claudication and biologic inflammation, a treatment modification was proposed. In the following months, inflammation was reduced and stabilized. The patient was then proposed to participate to a SET programme.

![Computed tomography angiography (maximum intensity projection 3D reconstruction) showing multiple stenoses/occlusions of iliac and femoral arteries.](yty123f1){#yty123-F1}

Physical examination
====================

Physical examination before beginning of SET revealed high blood pressure values (systolic blood pressure 151 mmHg; diastolic blood pressure 101 mmHg) with a normal resting heart rate. Peripheral pulses were present at the femoral artery level bilaterally and not perceived distally. Respiratory examination revealed no abnormalities.

Functional assessments
======================

Functional assessments were performed before and following SET.

Walking performances
--------------------

### Constant-load treadmill test

This test was performed at 3.2 km h^−1^ with a 12% slope to determine pain-free walking distance (PFWD) and maximal walking distance (MWD). Calf StO~2~ was monitored both at rest and during exercise with continuous wave NIRS (PortaMon, Artinis, The Netherlands). Near-infrared spectroscopy probe was placed over the lateral gastrocnemius muscle corresponding to the maximum girth of the calf of the most affected leg. Near-infrared spectroscopy probe was positioned with 3.5 cm inter-optode spacing. The signal was recorded at 10 Hz and a differential pathlength factor of 6.0 was used.

### Six-minute walking test

This test was performed in an indoor 50 m-corridor to determine the 6 min-walking distance (6MWD). Patient was asked to walk as much as possible within 6 min. At the end of the test, patient evaluated leg pain using a visual analogue scale ('no pain': 0 and 'worst imaginable pain': 10).

Physical function
-----------------

Lower limb function was assessed by means of the Short Physical Performance Battery test and the stair climbing test.[@yty123-B8]^,^[@yty123-B9]

Supervised exercise training
============================

Supervised exercise training consisted of 36 sessions, three times a week, over a 12 week period. Each training session started with a 5--10 min warm-up and ended with a 5-min stretching cool-down period. One session weekly was mainly focused on strengthening of lower limbs and include different type of walking (heel and toe walking, skipping walking, side-to-side walking, power-jogger walking) and resistance exercises focused on the main muscle groups of the lower limbs performed with an elastic band. During the two other weekly sessions, outdoor Nordic walking was performed. Training session duration was progressively increased (from 30 to 55 min) according to patient's tolerance. The intensity was mainly set at 12--14 on the 15-grade Borg scale (moderate intensity).[@yty123-B10]

Follow-up and outcomes
======================

The patient completed the training programme. Walking performances (PFWD: +22%; MWD: +273%; 6MWD: +66%) and physical function of lower extremities (+20%) significantly increased ([*Table 1*](#yty123-T1){ref-type="table"}) and muscle oxygen desaturation during exercise was greater after SET (*Figure*[*2A* and *B*](#yty123-F2){ref-type="fig"}). Table 1Walking performances and physical function of lower extremities before and after the supervised exercise training programmeVariablesBeforeAfterChange (%)Walking performance PFWD (m)90.0110.0+22 MWD (m)150.0560.0+273 6MWD (m)352.0585.0+66 Resting time during 6MWT (s)1100 6MWT~vas~6.22.0−68SPPB Stand test summed (s)30.030.00 4-m velocity test (m s^−1^)1.11.6+43 5× chair stand test (s)14.05.9−58 SPPB total score10.012.0+20SCT (s)5.53.1−43[^1]

![Calf muscle oxygen saturation (StO~2~) (*A*) and delta StO~2~ (ΔStO~2~) (*B*) at rest (StO~2R~), during the first 2 minutes of effort and at the pain-free walking distance (PFWD) and maximal walking distance (MWD). StO~2R~ was recorded after 3 min of standing before exercise. Each time point was calculated as the average StO~2~ during the last 15 s and ΔStO~2~ was calculated as the StO~2~ at each time point minus the baseline StO~2~.](yty123f2){#yty123-F2}

Review of the literature
========================

We performed a review of the literature on the topic of exercise training and arteritis in Pubmed and Embase ([Supplementary material online](#sup1){ref-type="supplementary-material"}). After screening procedure, we found two publications (one article and one case report; [*Table 2*](#yty123-T2){ref-type="table"}). Table 2Summary of studiesReferencesArteritis*n*GenderAgeBMIExercise trainingMain findingsLima *et al*.[@yty123-B5]Arteritis with no identifiable cause1Male3329.416-week unsupervised ETPatient were instructed to walk 1 h/day until maximum claudication pain at least five times per weekWeekly phone to monitor training adherence↑ in claudication distance and total walking distance during treadmill and 6-min walking test ↑ in QoL (assessed with SF-36) ↓ SBP, DBP, rate pressure product, and LF/HF ratioOliveira *et al*.[@yty123-B3]TAK6Female35.3 ± 6.626.6 ± 4.612-week SET (2×/week)30--50 min (gradually increased) of treadmill walkingHR between the VT and RCP was used to determine exercise intensity during the training sessions↑ muscle strength and physical function ↑ time to reach VT = V'O~2peak~, time-to-exhaustion = endothelial function = QoL (assessed with SF-36 and HAQ) ↓ TNF ↑ VEGF and PDGF AA[^2]

Discussion
==========

Exercise training is poorly investigated in patients with arteritis. Present results show that walking performances and physical function increase after SET in a TAK patient. In addition, we observed a greater muscle oxygen desaturation during exercise in the post-training condition.

The improvements of walking performance are in line with previous observations reported in LEAD patients.[@yty123-B11] One of the possible underlying mechanism associated with walking improvement may reside at the skeletal muscle level. It has recently been shown that exercise training may increase microvascular skeletal muscle blood flow during exercise in LEAD patients.[@yty123-B12] This is probably related to improvements in endothelium-dependent vasodilation and increased capillary density.[@yty123-B6]^,^[@yty123-B12]^,^[@yty123-B13] These adaptive responses may lead to increased oxygen extraction from the skeletal muscle, and therefore improve muscle oxidative metabolism during exercise.[@yty123-B6]^,^[@yty123-B12] Therefore, the greater muscle oxygen desaturation (i.e. increased oxygen extraction) during exercise observed after SET in our patient, may be related to an improved microvascular milieu leading to a better match between muscle oxygen supply and demand during exercise. These results may help to explain, at least partly, the observed increased walking performances and exercise tolerance and contributing to new mechanistic insights following exercise training in TAK patients. In addition, physical function of lower extremities also increased after SET, confirming recent results in TAK patients.[@yty123-B3]

Conclusion
==========

Beneficial effect of SET in non-atherosclerotic patients will need to be confirmed in a properly conducted randomized control trial. However, based on our findings and on previous results, SET seems to be beneficial and may be recommended in TAK patients.

Supplementary Material
======================
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[^1]: MWD, maximal walking distance; 6MWD, six-minute walking distance; 6MWT~vas~, visual analogical scale at the end of the 6-min walking test; PFWD, pain-free walking distance; SCT, stair climbing test; SPPB, short physical performance battery.

[^2]: DBP, diastolic blood pressure; HAQ, Health Assessment Questionnaire; HR, heart rate; LF/HF ratio, ratio of the low- and high-frequency bands in heart rate variability; PDGF AA, platelet-derived growth factor; QoL, quality of life; RCP, respiratory compensation point; SBP, systolic blood pressure; SET, supervised exercise training; SF-36, medical Outcome Study Short-Form 36 General Health Survey; TAK, Takayasu arteritis; TNF, tumour necrosis factor; VEGF, vascular endothelial growth factor; V'O~2peak~, peak oxygen uptake; VT, ventilatory threshold; ↑, increase; ↓, decrease; =, similar.
